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SPECC1L deficiency results in 
increased adherens junction 
stability and reduced cranial neural 
crest cell delamination
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Everett G. Hall1, Edina Kosa1, Kelly M. Stumpff1, Guerin J. Smith1, Lenore Pitstick2, 
Eric C. Liao3, Bryan C. Bjork2, Andras Czirok1 & Irfan Saadi1
Cranial neural crest cells (CNCCs) delaminate from embryonic neural folds and migrate to pharyngeal 
arches, which give rise to most mid-facial structures. CNCC dysfunction plays a prominent role in 
the etiology of orofacial clefts, a frequent birth malformation. Heterozygous mutations in SPECC1L 
have been identified in patients with atypical and syndromic clefts. Here, we report that in SPECC1L-
knockdown cultured cells, staining of canonical adherens junction (AJ) components, β-catenin and 
E-cadherin, was increased, and electron micrographs revealed an apico-basal diffusion of AJs. To 
understand the role of SPECC1L in craniofacial morphogenesis, we generated a mouse model of 
Specc1l deficiency. Homozygous mutants were embryonic lethal and showed impaired neural tube 
closure and CNCC delamination. Staining of AJ proteins was increased in the mutant neural folds. 
This AJ defect is consistent with impaired CNCC delamination, which requires AJ dissolution. Further, 
PI3K-AKT signaling was reduced and apoptosis was increased in Specc1l mutants. In vitro, moderate 
inhibition of PI3K-AKT signaling in wildtype cells was sufficient to cause AJ alterations. Importantly, 
AJ changes induced by SPECC1L-knockdown were rescued by activating the PI3K-AKT pathway. 
Together, these data indicate SPECC1L as a novel modulator of PI3K-AKT signaling and AJ biology, 
required for neural tube closure and CNCC delamination.
Cranial neural crest cells (CNCCs) are specified in the dorsal neuroectoderm and delaminate from the 
neuroepithelium of the developing neural folds through a process that involves epithelial-mesenchymal 
transition (EMT)1–3. Premigratory epithelial CNCCs break down their cell-cell junctions and become 
migratory mesenchymal CNCCs, which populate the first and second pharyngeal arches, and give rise to 
the majority of craniofacial cartilage. Thus, genes that modulate CNCC function are frequently perturbed 
in the etiology of craniofacial congenital malformations such as orofacial clefts3–7, which are among the 
most frequent birth malformations affecting 1/800 births in the U.S. alone8.
CNCC delamination occurs simultaneously with anterior neural tube closure between mouse embry-
onic days 8.5 and 9.5. Many mouse mutants of genes associated with orofacial clefts also manifest some 
form of neural tube defects, including Irf69,10, Ghrl310, Cfl111 and Pdgfrα12. However, the neural tube clo-
sure and CNCC delamination processes can be considered independent since the Splotch (Pax3) mouse 
mutant shows neural tube closure defects without any effect on CNCC delamination or migration13,14. 
Additional mouse models with defects in CNCC delamination and neural tube closure will help delineate 
the shared molecular underpinnings of these two processes.
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Delamination of CNCCs from the neural epithelium requires dissolution of adherens junctions (AJs), 
composed of a protein complex, containing E-cadherin, β -catenin, α -E-catenin and α -actinin among 
others, tethered to actin filaments2. Studies where E-cadherin is overexpressed in the neural folds, show 
reduced or delayed delamination of CNCCs. Conversely, down-regulation of E-cadherin results in early 
delamination15,16. Many factors that mediate EMT during CNCC delamination are transcription factors 
(AP2α , Id2, FOXD3, SNAIL, TWIST, SOX10) and extracellular matrix (ECM) remodeling proteins such 
as matrix metalloproteases (MMPs), however, direct cytoskeletal regulators of CNCC AJs are not yet 
known. The PI3K-AKT pathway is known to antagonize E-cadherin levels, primarily from cancer stud-
ies17. Recent studies show that loss of murine PDGFα based PI3K-AKT signaling leads to craniofacial 
malformations including cleft palate and neural tube defects12. However, a link between the PI3K-AKT 
pathway and AJ stability in CNCC delamination is not clear.
Previously, we identified SPECC1L as the first gene mutated in two individuals with a severe cleft 
that extends from the oral cavity to the eye, termed Oblique Facial Cleft (ObFC) or Tessier IV clefts18. 
SPECC1L mutations have since been identified in two multi-generation families with autosomal domi-
nant Opitz G/BBB syndrome (OMIM #145410), where affected individuals manifest hypertelorism and 
cleft lip/palate19, and in a family with Teebi hypertelorism syndrome (OMIM #145420)20. More than 
half of Opitz G/BBB syndrome cases are X-linked (OMIM #300000), caused by mutations in MID1 
gene21, which encodes a microtubule-associated cytoskeletal protein22. We proposed that SPECC1L, also 
a microtubule- and actin cytoskeleton-associated protein, may mediate transduction of signals required 
to remodel the actin cytoskeleton during cell adhesion and migration18. Using in vitro and in vivo studies, 
we now describe SPECC1L as a novel regulator of AJ stability through PI3K-AKT signaling. At the cel-
lular level, SPECC1L deficiency resulted in reduced levels of pan-AKT protein and increased apico-basal 
AJ dispersion, which was rescued by chemical activation of the AKT pathway. In vivo, Specc1l-deficient 
embryos showed neural tube closure failure and reduced CNCC delamination. Thus SPECC1L functions 
in the highly regulated cell adhesion based signaling required for proper CNCC function during facial 
morphogenesis.
Results
SPECC1L is localized at cell boundaries in cultured cells upon confluency. To characterize the 
role of SPECC1L at the cellular level, we used the SPECC1L-deficient U2OS osteosarcoma stable cell line 
described previously18. These stable SPECC1L-knockdown (kd) U2OS cells have a moderate (60–70%) 
reduction in SPECC1L transcript and protein levels with defects in migration and actin cytoskeleton 
reorganization18. In contrast, a severe transient reduction in SPECC1L has been shown to cause mitotic 
defects23. Upon further characterization, we find that our stable SPECC1L-kd cells changed morphology 
upon very high confluency (Fig. 1). Individual control and kd cells at low confluency appeared similar 
(Fig. 1A,D). Twenty-four hours after confluency, control cells maintained their cuboidal shape (Fig. 1B,E), 
while SPECC1L-kd cells elongated (Fig.  1C,F). The extent of this cell shape change was captured by 
in vivo live-imaging of control and kd cells (Movie 1). To determine the role of SPECC1L in confluent 
cells, we first examined its expression. We found that SPECC1L protein level was increased upon conflu-
ency (Fig. 1G) without an increase in SPECC1L transcript levels (Fig. 1H). Furthermore, SPECC1L pro-
tein accumulated at cell-cell boundaries with increasing cell density (Fig. 2A–E), in a pattern overlapping 
with that of membrane-associated β -catenin (Fig. 2A’–E’). Given the association of SPECC1L with actin 
cytoskeleton18,23, we hypothesized that SPECC1L interacts with actin-based adherens junctions (AJs).
SPECC1L deficient cells show abnormal staining and apico-basal dispersion of adherens 
junction proteins. Next we sought to determine the effects of SPECC1L deficiency on AJs. We used 
several markers associated with AJs, including canonical components F-Actin, Myosin IIb, β -catenin, 
and E-cadherin24–27. As previously reported, actin stress fibers were increased in SPECC1L-kd cells 
(Fig. 3A,B)18. Myosin IIb, associated with actin filaments, showed a similar increase in SPECC1L-kd cells 
in vitro (Fig. 3C,D). AJ-associated β -catenin, which binds to cadherins at the cell membrane, showed a 
normal “honey-comb” pattern of expression in control cuboidal cells (Fig. 3E,G). Interestingly, in planar 
images using confocal microscopy, β -catenin (Fig.  3E,F) and E-cadherin (Fig.  3G,H) staining at the 
cell membrane in confluent SPECC1L-deficient cells showed a drastically expanded staining pattern. 
This expansion in AJ-associated β -catenin staining in kd cells was most evident upon confluency, but 
appeared to precede the cell shape change (Fig.  2F–J,F’–J’). To determine the physical nature of this 
expanded AJ staining, we examined the cell boundaries in the apico-basal plane of SPECC1L-kd U2OS 
cells (Fig. 3I,J) using transmission electron microscopy (TEM). Compared to control cells (Fig. 3I), which 
had distinct electron-dense regions indicating AJs (arrowheads), the kd cells (Fig.  3J) showed a large 
contiguous region of high electron density, suggesting extensive dispersion of AJs along the apico-basal 
plane. Also, in lateral sections, we observed widespread ruffling of the cell membrane in the kd cells (Fig. 
S1A,B), accounting for the expanded striated pattern of β -catenin and E-cadherin staining (Fig. 3F,H). 
In support of a role for SPECC1L in AJs, β -catenin co-immunoprecipitated with SPECC1L in lysates 
from confluent U2OS cells (Fig. 3K). Together with expanded immunostaining of AJ markers, the TEM 
analysis is consistent with our hypothesis that SPECC1L deficiency increased apico-basal density and 
dispersion of AJs.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:17735 | DOI: 10.1038/srep17735
Specc1l deficiency leads to incomplete neural tube closure and reduced CNCC delamina-
tion. To understand the role of SPECC1L in craniofacial morphogenesis, we created a mouse model of 
Specc1l deficiency using two independent gene-trap ES cell lines - DTM096 and RRH048 (BayGenomics, 
CA), which trap Specc1l transcripts in introns 1 and 15 respectively (Fig. 4A, Fig. S2). Genomic location 
of gene-trap vector insertion was identified by whole-genome sequencing and verified by PCR (Fig. S2). 
Both gene-trap constructs also afford in-frame Specc1l-lacZ reporter fusion upon trapping. Thus, lacZ 
expression, as determined by X-gal staining, was used as a proxy for Specc1l expression. Both alleles show 
a similar lacZ expression pattern with the DTM096 gene-trap in intron 1 showing stronger expression 
than RRH048 in intron 15 (not shown). Specc1l is expressed broadly, however, expression is particu-
larly robust in the neural folds at E8.5 (Fig.  4B), the neural tube and facial prominences at E9.5 and 
E10.5 (Fig.  4C,D), and in the developing limbs and eyes at E10.5 (Fig.  4D). We previously reported 
that SPECC1L expression in the first pharyngeal arch at E10.5 is present in both the epithelium and the 
underlying mesenchyme18, consistent with CNCC lineage. To validate expression of SPECC1L in CNCCs, 
we co-stained for SPECC1L and NCC markers AP2-alpha (AP2A) and SOX10 in E8.5 neural folds 
(Fig. 4E–J) and in E9.5 cranial sections (Fig. 4K–P). At E8.5, SPECC1L stains the neural folds broadly 
(Fig.  4E,H), including cells stained with the NCC markers (Fig.  4G,J). At E9.5, SPECC1L (Fig.  4K,N) 
strongly stains migratory CNCCs co-stained with AP2A (Fig. 4L,M) or SOX10 (Fig. 4O,P).
Figure 1. SPECC1L-knockdown cells elongate upon high confluency. (A–F) Compared to control 
U2OS cells (A–C), SPECC1L-knockdown cells (D–F) elongate upon high confluency (F). Three (T1, T3, 
T6) of the six time-points we chose for various cell densities are shown here. (G) Western blot analysis 
shows that SPECC1L protein is stabilized at high, compared to low confluency, in control cells. SPECC1L 
immunoblot shows an expected 120 kD band and a higher molecular weight band (*) that is likely modified 
post-translationally. The western blot analyses were performed under the same conditions for low and high 
confluence. The images shown for SPECC1L at low and high confluence are taken from a single blot. The 
same blot was stripped and re-probed with β -actin antibody. (H) Quantitative RT-PCR analysis shows 
no significant change in SPECC1L transcript levels. Error bars represent SEM from four independent 
experiments.
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Intercross matings between Specc1lDTM096/+ and Specc1lRRH048/+ heterozygous mice showed that the 
two gene-trap alleles failed to complement each other, and that compound heterozygous and embryos 
homozygous for either gene trap allele are embryonic lethal (Table S1). The Mendelian ratios indicate 
reduced survival of heterozygotes at birth (1.34 vs. 2.0 expected). We noted a low incidence of perinatal 
lethality in heterozygotes; some with craniofacial malformations (Fig. S3). However, the low penetrance 
of these perinatal craniofacial phenotypes makes it difficult to study the underlying pathophysiologi-
cal mechanism. Therefore, we focused on the embryonic lethal phenotype of the Specc1l homozygous 
mutant.
The majority of Specc1lDTM096/RRH048 compound heterozygous or homozygous mutant embryos failed 
to thrive beyond E9.5–10.5 (Fig. 5A–D), with a failure of the neural tube to close anteriorly (Fig. 5B,D), 
and sometimes posteriorly (not shown). This cranial neural tube closure defect was accompanied by 
a large proportion of CNCCs, marked by DLX2, to remain in the neural folds at E10.5, suggesting 
a failure to delaminate (Fig.  5A’–D’). To determine if there was also a reduction in overall specifica-
tion of CNCCs, we marked the CNCC lineage with GFP in our gene-trap lines with Wnt1-Cre and 
ROSAmTmG. We flow-sorted the GFP+ NCCs and GFP- (RFP+ ) non-NCCs from whole embryos. At 
E9.5, the proportion of flow-sorted GFP-labeled CNCCs did not change significantly between WT and 
mutant embryos (not shown), indicating normal CNCC specification. Thus, we hypothesized that the 
Figure 2. SPECC1L is stabilized at cell-cell boundaries similarly to β-catenin. (A–E) We picked six time-
points (T1–T6) representing a range of cell densities to standardize analysis of cell shape and AJ change in 
SPECC1L-knockdown (kd) U2OS cells. First five of these time-points include individual cells (T1), 50–70% 
confluency with small cell clusters (T2), confluency without kd cell shape change (T3), shape change in 
kd cells (T4), and 24 hrs post shape change in kd cells (T5). SPECC1L protein is mostly dispersed within 
the cytoplasm at T1 (A), but is observed to accumulate at cell-cell boundaries at subsequent time-points 
(B–E), arrows). (F–J) β -catenin shows a similar accumulation at cell-cell boundaries in association with AJ 
complex. (A’–E’) SPECC1L and β -catenin show overlapping staining at cell boundaries at high cell densities 
(arrows). (F’–J’) In SPECC1L-kd cells, β -catenin staining appears normal at low cell densities (F’–H’), but is 
expanded upon cell shape change (I’,J’; arrows), indicating altered AJs. Bars = 10 μ m.
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Figure 3. SPECC1L-kd U2OS cells show altered expression of adherens junction markers. (A–H) Increased 
F-actin staining in kd cells at 48 hours post-confluency (T6; A,B). Altered F-actin associated Myosin IIb staining 
(C,D). Smooth pattern of β -catenin and E-cadherin membrane staining in control cells (E,G) is expanded in 
SPECC1L-kd cells (F,H). Bars = 10 μ m. (I–J) Electron micrographs looking at apico-basal cell-cell boundary. 
Control cells show distinct electron-dense regions, indicating adherens junctions (I, arrow). In contrast, the entire 
apico-basal boundary appears electron-dense in SPECC1L-kd cells (J, arrows), suggesting increased density and 
dispersion of adherens junctions. (K) β -catenin co-immunoprecipitation with SPECC1L in lysates from confluent 
U2OS cells. The image is taken from a single blot, and represents one of four independent experiments.
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residual staining with Wnt1-Cre and DLX2 in the open neural folds (Fig. 5B’,D’) was due to a defect in 
CNCC delamination, possibly due to increased density or dispersion of AJs, as observed in SPECC1L-kd 
cells. We used NCC markers SOX10, AP2A, and DLX2 to confirm the presence of CNCCs in the neural 
folds (Fig.  5E–R). At E8.5, neural fold staining is observed with all three NCC markers in both WT 
(Fig.  5E,G,I) and Specc1l mutant (Fig.  5F,H,J) sections. At E9.5, while NCC markers stain migratory 
NCCs in WT sections (Fig. 5M,O,Q), residual NCC staining is present in the open neural folds of Specc1l 
mutant embryos (Fig. 5N,P,R). Since SOX10 and DLX2 mark migratory CNCCs, this result indicates that 
SPECC1L deficient CNCCs attain post-migratory specification but fail to emigrate from the neural folds.
Specc1l mutant tissue recapitulates in vitro adherens junction changes. To test our hypoth-
esis that reduced delamination is due to altered AJs, we investigated the AJ markers in the open neural 
folds of Specc1l mutant embryos (Fig. 5S–Z). We observed increased actin stress fibers (Fig. 5S,T) and 
Figure 4. Specc1l expression and overlap with the neural crest cell lineage. (A) Schematic representation 
of murine Specc1l gene indicating insertion of genetrap vectors in ES cell clones DTM096 (intron 1) and 
RRH048 (intron 15). (B–D) Heterozygous Specc1lDTM096 embryos stained for lacZ, representing Specc1l 
expression, from E8.5 to E10.5. NE = neuroectoderm, NF = neural folds, PA1 = 1st pharyngeal arch. (E–P) 
Co-immunostaining of SPECC1L with NCC markers AP2A and SOX10 in E8.5 neural folds (NF; E–J) and 
in E9.5 cranial sections (K–P). SPECC1L staining is broadly observed in the E8.5 neural folds (E,H; arrows), 
including in cells marked by AP2A (F,G; arrows) and SOX10 (I,J; arrows). At E9.5, SPECC1L strongly stains 
migrating CNCCs (K,N; arrows) marked by AP2A (L,M; arrows) and SOX10 (O,P; arrows).
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Figure 5. Specc1l deficiency leads to defects in neural tube closure, cranial neural crest cell delamination 
and AJs. (A,B’) E9.5 WT (A) embryo with migratory cranial neural crest cells (CNCCs) marked with 
Wnt1-Cre (A’). In contrast, Specc1l mutant embryo shows open neural folds (B), arrow) with CNCCs that 
have still not migrated (B’, arrow). (C,D’) Brightfield images (C,D) and CNCC marker DLX2 immuno-
stain (C’,D’) of E10.5 WT (C,C’) and Specc1l mutant (D,D’) embryos. In E10.5 WT embryo, DLX2 positive 
CNCCs populate the branchial arches (C’, arrowhead), while in the mutant significant staining remains in 
open neural folds (D’, arrow) with some staining in the 1st pharyngeal arch (D’, arrowhead), indicating poor 
CNCC delamination and migration. E-R) Sections from WT and Specc1l mutant embryos at E8.5 (E–L) and 
at E9.5 (M–R) were stained with NCC markers SOX10 (E,F,M,N), AP2A (G,H,O,P), and DLX2 (I,J,Q,R). 
At E8.5, NCC staining is observed in the neural folds (NF) of WT and mutant sections. Co-staining of 
SOX10 and β -catenin in E8.5 WT (K) and mutant (L) shows increased β -catenin staining at cell boundaries 
in the neural folds. At E9.5, migratory CNCC staining is observed in WT (M,O,Q), while in mutants 
undelaminated CNCCs stain the open neural folds (N,P,R). (S–Z) Analysis of AJ markers in vivo in WT 
and Specc1lDTM096/RRH048 mutant E9.5 embryo coronal sections. The approximate plane of section is indicated 
in the top-right corner. Increased F-actin (S,T) and Myosin IIb (U,V) staining is observed in mutant tissue 
sections. Similarly to in vitro results in Fig. 3, expanded β -catenin (W,X) and E-cadherin (Y,Z) membrane 
staining is observed in vivo in mutant embryos. (AA-BB) Electron micrograph of WT embryo section 
looking at apico-basal cell boundary shows a distinct electron-dense region indicating adherens junction 
(AA, arrowhead). In contrast, the entire apico-basal boundary appears electron-dense in Specc1l mutant 
embryo section (BB, arrowheads), suggesting increased density and dispersion of adherens junctions.
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8Scientific RepoRts | 6:17735 | DOI: 10.1038/srep17735
concomitant increased localization of Myosin IIB staining to the actin fibers (Fig. 5U,V). Importantly, we 
saw increased staining of β -catenin (Fig. 5W,X) and E-cadherin (Fig. 5Y,Z) at cell-cell boundaries. We 
also examined β -catenin staining of NCCs in the neural folds of E8.5 embryos (Fig. 5K,L). The β -catenin 
staining appears more robust in Specc1l mutant neural folds (Fig. 5L vs. K), suggesting that changes in AJs 
have commenced. In electron micrographs of cranial sections from E9.5 embryos, we again observed an 
increase in dispersed electron-dense staining in Specc1l mutant embryos compared to WT (Figs 5AA,BB 
and S1E–H). Taken together, these results validate our in vitro findings in SPECC1L-kd U2OS cells, and 
indicate that abnormal staining of AJs precedes CNCC delamination in our mutant embryos.
Reduced PI3K-AKT signaling and increased apoptosis in SPECC1L deficient cells. Given the 
known antagonistic relationship of AKT activity to E-cadherin stability17,28, we hypothesized involve-
ment of PI3K-AKT signaling. In addition, we observed sub-epidermal blebbing in some of our mutant 
embryos that escape E9.5–10.5 lethality (< 5%), and instead arrest at approximately E13.5 (Fig. S3). 
Sub-epidermal blebbing is a hallmark of reduced PDGFRα -based PI3K-AKT signaling12. Fantauzzo 
et al. (2014) reported that disruption of PDGFRα -based PI3K activation in PdgfraPI3K/PI3K mutant embryos 
results in sub-epidermal blebbing, neural tube defects, and cleft palate phenotypes. Indeed, pan-AKT 
and active phospho-Ser473-AKT levels were reduced in vivo in Specc1l mutant tissue (Fig. 6A–D), prior 
to embryonic arrest at E9.5. Reduced phospho-Ser473-AKT level was likely entirely due to reduced 
pan-AKT levels in vivo (Fig. 6E) and in vitro (Fig. 6F). The in vitro reduction was only present at high 
confluency of U2OS cells upon cell shape and AJ density changes (Fig.  6D). Thus, our data suggest 
SPECC1L is a novel positive regulator of PI3K-AKT signaling in craniofacial morphogenesis.
We next examined markers of proliferation and apoptosis. We did not observe any differences in 
proliferation in E9.5 embryos (Fig. 6E,G vs. I) as measured by KI67 staining, with a proliferative index 
of 82.5% for WT and 86.5% for Specc1l mutant (p < 0.56, Fisher exact test). Similarly, we did not observe 
any difference in apoptosis as measured by cleaved Caspase 3 staining in neural folds at E8.5, prior 
to embryonic arrest (not shown). In contrast, apoptosis was markedly increased throughout the E9.5 
mutant embryo (Fig. 6F,H vs. J). This global increase in apoptosis is consistent with reduced PI3K-AKT 
signaling and early embryonic lethality29–31.
Upregulation of PI3K-AKT pathway rescues SPECC1L-kd phenotype. Next, to confirm a causal 
role for PI3K-AKT signaling in AJ change in our kd cells, we chemically altered the pathway in control 
and kd cells (Fig. 7A–F). We used the cell shape change phenotype observed in confluent SPECC1L-kd 
cells as a marker, which we quantified using the ratio of the longest dimension (length) and the corre-
sponding perpendicular dimension (width). A relatively round or cuboidal cell would be expected to give 
a ratio of 1 (Fig. 7G). In addition to cell shape, we confirmed the effect on AJs through β -catenin staining 
(Fig. 7A’–F’). Inhibition of the PI3K-AKT pathway using Wortmannin was sufficient to alter cell shape 
(Fig. 7A,C) and AJs (Fig. 7A’,C’) in control cells. The PI3K-AKT activator, SC-79, did not affect cell shape 
(Fig. 7A,E) or AJ expansion (Fig. 7A’,E’) in control cells. In SPECC1L-kd cells, further down-regulation 
of PI3K-AKT pathway resulted in increased apoptosis (Fig.  7B,D) with drastically expanded staining 
for β -catenin (Fig. 7B’,D’), consistent with our severe mutants in vivo. Importantly, upregulation of the 
PI3K-AKT pathway drastically ameliorated the cell shape (Fig.  7B,F) and AJ (Fig.  7B’,F’) phenotypes. 
As stated above, changes in cell shape were quantitated as a cell circularity ratio (CCR), and compared 
for significance (Fig.  7G). Indeed, in control cells (Fig.  7G, CCR = 1.56), Wortmannin treatment was 
sufficient to significantly change cell shape (Fig. 7G, CCR = 3.61, p < 2.4 × 10−9), which was similar in 
extent to that seen in SPECC1L-kd cells (Fig. 7G, CCR = 3.46). Wortmannin treatment of SPECC1L-kd 
cells (Fig. 7G, CCR = 3.60, not significant) did not affect cell elongation any further than untreated kd 
cells (Fig.  7G, CCR = 3.46, not significant) or Wortmannin-treated control cells (Fig.  7G, CCR = 3.61, 
not significant). Most important, SC-79 AKT activator rescued the elongated cell shape phenotype of 
SPECC1L-kd cells (Fig. 7G, CCR = 1.74, p < 6.2 × 10−12). These results substantiate that SPECC1L regu-
lates PI3K-AKT signaling, and indicate that moderate reduction in SPECC1L affects cell adhesion, while 
severe reduction can lead to apoptosis (Fig. 8).
Discussion
Dissolution of AJs is required for pre-migratory CNCCs to delaminate from the neural epithelium of the 
anterior neural folds1,15,32. The increased staining of AJ components and loss of apico-basal asymmetrical 
distribution of AJs in SPECC1L-deficient cells in vitro and in vivo, combined with physical proximity 
of SPECC1L with β -catenin indicates a role for SPECC1L in maintaining localized stability of AJs by 
properly organizing the actin cytoskeleton. The association of SPECC1L with the actin cytoskeleton 
and β -catenin combined with an increase in condensed actin filaments upon SPECC1L deficiency are 
consistent with the observed increase in AJ density. Another possibility is that increased actin fibers in 
SPECC1L deficient cells lead to altered tension between cells. As cell tension can impact AJ dynamics33, 
a change in tension may lead to more dispersed AJs34. Either alteration can consequently affect CNCC 
delamination.
Wnt1 is expressed in the early neural folds that give rise to neural crest cells. Thus, Wnt1-cre lineage 
tracing marks both pre-migratory and migratory NCCs35. However, Wnt1 also marks lineage of dorsal 
brain tissues that also arise from the early neural folds35,36, leaving a possibility that the Wnt1-marked 
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staining in our E9.5 mutant open neural folds were not CNCCs. Our positive staining with NCC markers 
AP2A and SOX10 confirms that the open neural folds of the Specc1l mutant embryos indeed contain 
CNCCs. Furthermore, since AP2A and SOX10 are markers for early migrating NCCs, the positive stain-
ing indicates that these cells are post-migratory CNCCs that fail to delaminate by E9.5.
Figure 6. Specc1l mutant embryos show reduced PI3K-AKT signaling and increased cell death. (A–E) 
E8.5 (A,B) and E9.5 (C,D) cranial sections or E9.5 lysates (E) from Specc1l mutant embryos show decreased 
levels of active phospho-S473-AKT and pan-AKT protein, compared to WT control. The western blot 
analyses were performed under the same conditions for WT and mutant lysates. The images shown for 
SPECC1L are taken from a single blot. The same blot was stripped and re-probed with pan-AKT and then 
β -actin antibodies. Pan-AKT level in E8.5 neural folds (A,B) and phospho-S473-AKT level in E9.5 cranial 
section are markedly reduced. (F) A similar reduction is seen in pan-AKT levels in SPECC1L-kd U2OS cell 
lysates collected at high confluency. The error bars represent SEM from quantitation of three independent 
western blots. (G–J) Sections of WT embryos at E9.5 show cell proliferation (G,G’) with negligible apoptotic 
activity (H,H’) through KI67 and cleaved Caspase 3 staining, respectively. In Specc1l mutant embryos, there 
is comparable cell proliferation (I), however, there is a striking increase in cells undergoing apoptosis (J).
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Figure 7. Upregulation of PI3K-AKT pathway can rescue SPECC1L-kd phenotype in vitro. (A–F’) 
Control (A,C,E) and SPECC1L-kd (B,D,F) cells were treated with PI3K-AKT pathway inhibitor Wortmannin 
(C,D) or activator SC-79 (E,F). Untreated control cells are cuboidal (A) with normal honey-comb pattern of 
β -cat staining (A’), while kd cells are elongated (B) with expanded β -cat staining (B’). Upon down-regulation 
of PI3K-AKT pathway, control cells are elongated (C) with β -cat expansion (C’), while kd cells begin 
to undergo apoptosis (D), similarly to our severe mutant embryos, and show extremely expanded β -cat 
staining (D’). Upon up regulation of PI3K-AKT pathway, control cells remain cuboidal (E) with normal 
β -cat staining (E’), while kd cells show much improved cell shape (F) and β -cat staining (F’), indicating 
rescue. (G) The extent of cell shape change in (A–F) were quantitated using a cell circularity ratio (CCR) 
of longest dimension (length) and the corresponding perpendicular dimension (width) using MetaMorph 
software. The no treatment (NT) SPECC1L-kd cells (CCR = 3.46) were significantly elongated than control 
cells (CCR = 1.56, p < 6.1 × 10−13). Wortmannin (Wort) inhibition of PI3K-AKT pathway in control cells 
was sufficient to cause a similar elongation of cell shape (CCR = 3.61, p < 2.4 × 10−9). Similarly, AKT 
activation with SC-79 in SPECC1L-kd cells was able to rescue the elongated cell shape back to control level 
(CCR = 1.74, p < 6.2 × 10−12). Wortmannin treatment of SPECC1L-kd cells resulted in increased apoptosis, 
but did not cause further increase in cell shape change (CCR = 3.60) beyond that observed in untreated kd 
(CCR = 3.46, ns) or Wortmannin-treated control cells (3.61). ns = not significant. Measurement of 50 cells 
+ /− S.E.M. is shown. Statistical differences were calculated using a Student’s t-test.
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Our data indicate that the molecular regulation of AJs by SPECC1L is mediated by PI3K-AKT sig-
naling. AKT signaling is reduced in SPECC1L-deficient cells and tissue. A direct role for PI3K-AKT 
signaling in craniofacial morphogenesis is supported by the findings of Fantauzzo et al. (2014) show-
ing that lack of PDGFRα -based activation of PI3K-AKT signaling leads to cleft palate phenotype. We 
also showed that inhibition of the PI3K-AKT pathway is sufficient to alter AJs and cell shape in U2OS 
cells. Consistent with our findings, Cain et al.37 have shown that in endothelial cells down-regulation 
of PI3K α 110 subunit led to a similarly expanded pericellular β -catenin staining, termed as increased 
“junctional index”. However, in their endothelial cells with already highly organized actin filaments, the 
down-regulation of PI3K-AKT pathway resulted in a relaxation of cell shape. In contrast, the SPECC1L-kd 
U2OS cells show elongated cell shape. This difference is likely cell-type specific. While down-regulation 
of PI3K-AKT signaling consistently affects the actin cytoskeleton, the effect on cell shape is dictated by 
altered tension resulting from changes in central actin fiber density and organization. In U2OS cells, 
we used the cell shape change only as a marker of the SPECC1L-deficient AJ change and rescue. Taken 
together, we propose that suppression of AKT pathway upon SPECC1L deficiency increases AJ stability 
and reduces delamination of the CNCCs.
Interestingly, pan-AKT levels are reduced in addition to phospho-473-AKT levels in vitro and 
in vivo upon SPECC1L deficiency, thus indicating regulation of PI3K-AKT signaling at the level of AKT 
protein stability or turnover. Both SPECC1L and MID1 genes, implicated in Opitz/GBBB Syndrome, encode 
proteins that stabilize microtubules18,22. The mechanism through which SPECC1L and MID1 mediate 
microtubule stabilization is not entirely clear. In the case of SPECC1L, this stabilization involves enhanced 
acetylation of a subset of microtubules18. Perhaps SPECC1L utilizes a similar mechanism to stabilize other 
proteins such as AKT. Acetylation of lysine residues in AKT protein has been shown to result in reduced 
membrane localization and phosphorylation38. In addition, K63 chain ubiquitination of the same lysine 
residues on AKT is required for its membrane localization and activation39,40. Of the few SPECC1L pro-
tein interactors identified in different high throughput yeast two-hybrid screens, four-CCDC841, ECM2942, 
Figure 8. Model of SPECC1L modulation of PI3K-AKT pathway and AJs. (A) Schematic summary of 
PI3K-AKT pathway inhibition and activation leading to AJ change and rescue, respectively. (B) A model 
proposing that SPECC1L stabilizes AKT protein.
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APC and UBE2I43 - participate in protein turnover or stability through ubiquitination or sumoylation. 
It is possible that SPECC1L participates in the post-translational modification of AKT lysine residues, 
affecting AKT stability. However, a definitive role for SPECC1L in AKT protein localization and stability 
is yet to be elucidated.
A severe deficiency in SPECC1L expression in vivo results in increased AJ marker staining and defec-
tive CNCC delamination, as well as in increased apoptosis and early embryonic lethality. Previous reports 
have shown that mouse mutants with increased levels of apoptosis have associated neural tube44–47 and 
craniofacial defects48. It is proposed that excessive cell death in the neural folds or pharyngeal arches 
may result in insufficient number of cells required for proper morphogenetic movement48–50. In contrast, 
our SPECC1L-deficient cell lines with moderate reduction in SPECC1L expression show only AJ changes 
without evidence of increased cell death. However, chemical inhibition of PI3K-AKT pathway in these 
kd cells does indeed lead to increased apoptosis. Thus, a moderate reduction in SPECC1L expression or 
function allows cell viability. This is consistent with the observation that rare Specc1l mutant embryos 
that escape E9.5 arrest - likely due to reduced gene-trapping efficiency - are able to close their neural 
tubes and arrest later in development, frequently with craniofacial defects (Fig. S3). Also consistent with 
this is the rare occurrence of Specc1l heterozygous embryos with craniofacial malformation - likely due to 
increased gene-trapping efficiency - and findings in zebrafish where morphants for one of two SPECC1L 
orthologs (specc1lb) lead to late embryonic phenotypes including a loss of mandible and bilateral clefts51. 
Thus, heterozygous SPECC1L loss-of-function mutations identified in human patients may lead to mild 
perturbation in SPECC1L function during craniofacial morphogenesis, sufficient to account for their 
orofacial clefts. SPECC1L-based modulation of cell-cell contacts may also play a role in palatogenesis 
and pharyngeal arch fusion. Further studies of SPECC1L function will help elucidate the role of transient 
cell-cell contacts in neuroepithelial cell movement during neural tube closure and in CNCCs during 
craniofacial morphogenesis.
Materials and Methods
Cell lines and antibodies. U2OS osteosarcoma control and SPECC1L-kd cells were previously 
described (Saadi et al. 2011). Anti-SPECC1L antibody was also previously characterized (Saadi 
et al. 2011). Antibodies against β -catenin (rabbit; 1:1000; Santa Cruz, Dallas TX) (mouse; 1:1000; Cell 
Signaling Technology, Danvers, MA), Myosin IIb (1:1000; Sigma-Aldrich, St. Louis, MO), E-cadherin 
(1:1000; Abcam, Cambridge, MA), AP2A (1:1000; Novus Biologicals, Littleton, CO), SOX10 (1:1000; 
Aviva Systems Biology, San Diego, CA), DLX2 (1:1000; Abcam, Cambridge, MA), phospho-Ser473-AKT 
(1:1000; Cell Signaling Technology, Danvers, MA), pan-AKT (1:1000; ThermoFisher Scientific, Waltham, 
MA), KI67 (1:1000; Cell Signaling Technology, Danvers MA), cleaved Caspase 3 (1:1000; Cell Signaling 
Technology, Danvers, MA), and β -actin (1:2500; Sigma-Aldrich, St. Louis, MO) were used as described. 
Actin filaments were stained using Acti-stain rhodamine phalloidin (Cytoskeleton, Denver, CO).
Cell shape change in U2OS cells. U2OS control and SPECC1L-kd cells were cultured in standard 
DMEM high glucose media supplemented with 10% fetal bovine serum (Life technologies, Carlsbad, 
CA). For AJ change, 2 × 105 cells were plated on 0.1% porcine gelatin treated glass (Sigma-Aldrich, St. 
Louis, MO), and observed for cell shape change. Cells were collected at various indicated timepoints: 
4 hours post plating (t = 1), 24 hours post plating (t = 2), confluency without cell shape change (t = 3), 
cell shape change (t = 4), 24 hours following cell shape change (t = 5), and 48 hours following cell shape 
change (t = 6) (Figs.  1–3). To modulate the PI3K-AKT pathway, cells were cultured in described con-
centrations of PI3K-AKT inhibitor, Wortmannin (TOCRIS Biosciences, Minneapolis, MN), or activator, 
SC-79 (TOCRIS Biosciences, Minneapolis, MN). Media with chemicals was replaced daily.
Live-imaging analysis. Time-lapse recordings were performed of live control and kd cells in regular 
culture conditions with a phase contrast image collected every 10 minutes over a period of seven days. 
Images were taken with a computer-controlled Leica DM IRB inverted microscope equipped with a pow-
ered stage and a 10 × N-PLAN objective, coupled to a QImaging Retiga-SRV camera. During imaging, 
cell cultures were kept at 37C in a humidified 5% CO2 atmosphere.
Mouse strains. Two gene trap ES cells lines, DTM096 and RRH048, from Mutant Mouse Regional 
Resource Center (UC Davis, CA) were used to generate Specc1l deficient mouse strains, designated 
Specc1lgtDTM096 and Specc1lgtRRH046. Briefly, 129/REJ ES cells were injected into C57BL6 blastocysts. The 
resulting chimeric male mice were crossed to C57BL6 females to identify progeny with agouti coat color. 
Presence of gene trap vector insertion was used to identify heterozygotes. The mice are maintained on 
a mixed 129/REJ; C57BL6 background. The location of the genetrap vector insertion site was verified 
by RT-PCR, genomic sequencing, and genetic complementation (Suppl. Fig.  1). For lineage-tracing of 
CNCCs, Specc1lGT double heterozygous mice with ROSAmTmG (#007576) and Wnt1-Cre (#003829) mice 
(Jackson Laboratories, Bar Harbor, ME) were intercrossed to generate Specc1l mutant embryos also car-
rying both ROSAmTmG and Wnt1-Cre alleles. All mouse experiments were carried out in accordance with 
protocols approved by the Institutional Animal Care and Use Committee at the University of Kansas 
Medical Center.
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X-gal staining. Embryos were fixed in (1% formaldehyde, 0.2% gluteraldehyde, 2 mM MgCl2, 0.02% 
NP-40, 5 mM EGTA) for 60 minutes at room temperature. Following fixation, color development in X-gal 
staining solution (5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl2, 0.01% 
sodium deoxycholate, 0.02% NP-40, 1 mg/ml X-gal) was performed at 37 °C for 1–6 hours. Embryos 
were post-fixed in 4% PFA and imaged.
Western blotting and immunostaining. For western blotting, cells were lysed in passive lysis buffer 
(Promega, Fitchburg, WI) with HALT protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) added. 
Lysates were electrophoresed on 12% polyacrylamide Mini-PROTEAN TGX precast gels (Bio-Rad, 
Hercules, CA) and transferred onto an Immobilon PVDF membrane (EMD Millipore, Billerica, MA). 
Membranes were blocked in 5% milk in PBS with 0.1% Tween. Antibodies were incubated either over-
night at 4 °C or for one hour at room temperature. Femto SuperSignal West ECL reagent (Thermo 
Scientific, Waltham, MA) was used to develop the signal. For immunostaining, embryos were fixed in 
4% PFA/PBS overnight and cryopreserved. Tissue cryosections were blocked in PBS containing 1% nor-
mal goat serum (Thermo Scientific, Waltham, MA) and 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, 
MO), followed by incubation in primary antibody overnight at 4 °C, and fluorescent secondary antibody 
(1:1000) for one hour at 4 °C. Stained sections were mounted in ProLong gold mounting media (Thermo 
Scientific, Waltham MA), and planar images were obtained using a Leica TCS SPE confocal microscope. 
Each immunostaining was performed as three independent experiments on cyrosections from at least 
two mutant embryos. A representative experiment is shown.
Coimmunoprecipitation. Cells were lysed in a modified RIPA buffer (20 mM Tris-HCl pH8.0, 1% 
NP-40, 130 mM NaCl, 10% glycerol, 2 mM EDTA, and HALT protease inhibitors (Sigma-Aldrich, St. 
Louis, MO)). Briefly, lysates were pre-cleared with protein G magnetic beads (Life technologies, Carlsbad, 
CA) followed by incubation with anti-SPECC1L antibody or IGG overnight at 4 °C. Protein G magnetic 
beads were used to pull-down SPECC1L and western blotting was performed using β -catenin antibodies 
described above. The co-IP experiment shown is representative of four independent experiments.
TEM analysis. Fixed cultured cells or mouse embryonic tissues were provided to the University of 
Kansas Medical Center Electron Microscopy Core. Briefly, samples were embedded in EMbed 812 resin 
(Electron Microscopy Sciences, Ft. Washington, PA), polymerized at 60 °C overnight, and sectioned with 
a Leica UC7 ultramicrotome equipped with a diamond knife, at 80 nm. Sections were imaged using a 
JEOL JEM-1400 Transmission Electron Microscope equipped with a Lab6 gun, at 100 kV.
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